The Motley Fool” recommends IQVIA Holdings as one of “3 Top Healthcare Stocks to Buy in February.” (Feb 11, 2018). IQVIA (formerly known as Quintiles IMS), “pharma’s go-to partner”, is the world’s largest clinical research organization and a trusted partner in drug development; the company can also help drug developers with the commercialization process, enabling IQVIA to make money from all facets of the drug development process. (The Motley Fool)